Clearmind Medicine Inc. Stock

Equities

CMND

CA1850534027

Biotechnology & Medical Research

Delayed Nasdaq 02:41:26 2024-05-15 pm EDT 5-day change 1st Jan Change
1.29 USD 0.00% Intraday chart for Clearmind Medicine Inc. -12.24% -54.09%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2022 - Sales 2023 - Capitalization 1.78M
Net income 2022 -9M Net income 2023 -8M EV / Sales 2022 -
Net cash position 2022 388K Net cash position 2023 5.51M EV / Sales 2023 -
P/E ratio 2022
-1.09 x
P/E ratio 2023
-0.09 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 92.25%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.55%
1 week-12.24%
Current month+8.61%
1 month+2.79%
3 months-4.44%
6 months-66.14%
Current year-54.09%
More quotes
1 week
1.23
Extreme 1.23
1.53
1 month
1.13
Extreme 1.13
1.80
Current year
0.92
Extreme 0.9205
3.58
1 year
0.92
Extreme 0.9205
20.40
3 years
0.92
Extreme 0.9205
657.00
5 years
0.92
Extreme 0.9205
657.00
10 years
0.92
Extreme 0.9205
657.00
More quotes
Date Price Change Volume
24-05-15 1.29 0.00% 63 624
24-05-14 1.29 0.00% 144,490
24-05-13 1.29 -7.86% 332,071
24-05-10 1.4 -6.67% 438,754
24-05-09 1.5 +2.04% 407,565

Delayed Quote Nasdaq, May 15, 2024 at 02:41 pm EDT

More quotes
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW